BD Welcomes Bilal Muhsin as EVP and President of Future Connected Care Segment

BD Announces Bilal Muhsin as New Executive Leader

On July 2, 2025, BD (Becton, Dickinson and Company), a prominent player in the global medical technology sector, introduced Bilal Muhsin as the new Executive Vice President and the President of its Future Connected Care segment. This appointment forms part of the company's strategic initiative, termed the New BD strategy, aimed at enhancing its organizational framework and innovative offerings in healthcare.

Bilal will be a vital member of the BD Executive Leadership Team and will report directly to Tom Polen, the chairman, CEO, and president of BD. His primary responsibility will be to lead the development and implementation of strategies that facilitate the successful transition into this newly structured segment over the coming months.

Under Bilal’s stewardship, the BD Connected Care initiative is set to harness the power of advanced analytics and artificial intelligence. The goal is to synergize BD’s industry-leading smart medical devices with these technologies to enhance the effectiveness of patient care. This, in turn, is expected to generate significant growth opportunities within new healthcare domains, including connected medication management, sophisticated workflow robotics, and smart monitoring solutions.

In his newly created role, Muhsin will be at the forefront of shaping BD's future Connected Care strategy. He is responsible for augmenting the organizational capabilities necessary for the company’s future direction, executing a robust commercial strategy, spearheading leading innovation initiatives, and ensuring operational excellence along with superior quality.

Tom Polen remarked, "Bilal's extensive knowledge of connected care technologies, software, and informatics will significantly influence BD's connected care advancements. He brings an acute focus on customer satisfaction, which is pivotal as we integrate groundbreaking, AI-driven technologies that will elevate safety, efficiency, and patient outcomes in healthcare. This is a crucial step in realizing our New BD strategy, aiming to position BD as a premier, differentiated MedTech leader. Bilal's expertise will be key in accelerating our growth and amplifying our impact on healthcare through innovative digital, robotic, and AI technologies."

Before joining BD, Muhsin dedicated 25 years to Masimo, a highly regarded health technology and consumer electronics firm, where he held various leadership roles, including that of Chief Operating Officer. His experience encompasses overseeing engineering, marketing, and regulatory sectors, demonstrating a thorough track record in medical engineering and healthcare software development. Moreover, he has garnered over 50 patents related to Medical Systems Communication, analytics, and patient monitoring systems, reflecting his substantial contributions to the field.

An advocate for educational excellence, Bilal holds a Bachelor of Science degree in Computer Science from San Diego State University. His emphasis on cutting-edge technologies aligns perfectly with BD's commitment to advancing global health through innovative medical solutions and systems.

BD has earned its reputation as one of the largest medical technology companies worldwide, committed to enhancing healthcare delivery across the globe. The company is devoted to supporting healthcare professionals and improving patient outcomes through pioneering technologies, services, and solutions. With a global workforce of over 70,000, BD collaborates with organizations to tackle major health challenges, thereby driving efficiency and accessibility in healthcare delivery.

For further insights on BD's initiatives and offerings, check out their official website at bd.com or engage with them through their social media platforms including LinkedIn, X (formerly Twitter), and Instagram.

In summary, Bilal Muhsin’s arrival at BD not only marks a significant leadership transition but also symbolizes the company’s robust commitment to utilizing advanced technologies in healthcare to foster improved outcomes for patients and healthcare professionals alike.